Clinical Focus

  • Anesthesia

Academic Appointments

  • Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

Professional Education

  • Board Certification, American Board of Anesthesiology, Adult Cardiac Anesthesiology (2023)
  • Board Certification, National Board of Echocardiography, Advanced Perioperative Transesophageal Echocardiography (2023)
  • Fellowship: UCSF Anesthesiology Fellowships (2023) CA
  • Board Certification: American Board of Anesthesiology, Critical Care Medicine (2022)
  • Board Certification: American Board of Anesthesiology, Anesthesia (2022)
  • Fellowship: Stanford University Critical Care Medicine Fellowship (2022) CA
  • Residency: UCSF Anesthesiology Residency (2021) CA
  • Medical Education: Columbia University College of Physicians and Surgeons (2017) NY

Contact

  • Clinical (Primary)  Anesthesia Department 300 Pasteur Dr Rm H3580 MC 5640 Stanford, CA 94305 (650) 725-8544 (fax)

Additional Clinical Info

Additional Info

All Publications

  • Early Need of Extracorporeal Membrane Oxygenation After Lung Transplantation: A Retrospective Cohort Study. ASAIO journal (American Society for Artificial Internal Organs : 1992) Banga, A., A Guenthart, B., Tulu, Z., Zhang, S., Choi, C. H., MacArthur, J. W., Dhillon, G. S. 2026

    Abstract

    The current study aimed to assess the national practice patterns of extracorporeal membrane oxygenation (ECMO) use during the early posttransplant period. We included patients in the United Network for Organ Sharing (UNOS) database aged greater than 18 years who underwent lung transplantation (LT) between January 1, 2017 and December 31, 2022 (n = 14,999). The study group was divided based on the need for ECMO at 72 hours after LT, as recorded in the database. We analyzed recipient, donor, and procedure-related variables as potential predictors of need for ECMO. One year survival was the primary outcome variable. The overall incidence of ECMO use after LT was 9% (1,357/14,999), with increasing yearly incidence (6.5%-10.7%). Several recipient variables were independently associated with post-LT ECMO use. Additionally, older donors, donation after circulatory death donors, use of machine perfusion, longer ischemia time, and bilateral LT were additional predictors. Patients with post-LT ECMO use had significantly higher 1 year mortality (30.5% vs. 9%, p < 0.001). It is concluded that post-LT ECMO use was independently associated with worse 1 year mortality. Extracorporeal membrane oxygenation is being increasingly deployed among patients with severe allograft dysfunction. The increase in incidence of post-LT ECMO use appears to be fueled by progressively higher-risk donors and recipients. Patients with post-LT ECMO use continue to experience markedly worse outcomes.

    View details for DOI 10.1097/MAT.0000000000002638

    View details for PubMedID 41521430

  • Prolonged Postoperative Euglycemic Diabetic Ketoacidosis in a Lung Transplant Recipient With Preoperative SGLT2 Inhibitor Use. Journal of cardiothoracic and vascular anesthesia Choi, C. H., Singh, S., Cheung, A. T., Vanneman, M., Madhok, J. 2024

    View details for DOI 10.1053/j.jvca.2024.03.007

    View details for PubMedID 38637210

  • Tricuspid Regurgitation: A Focus on Updated Interventional Anatomy and Pathophysiology. Journal of cardiothoracic and vascular anesthesia Venkataramani, R., Hershberger, A., Choi, C. H., Ng, V., Bhardwaj, A., Ramakrishna, H. 2023

    View details for DOI 10.1053/j.jvca.2023.07.010

    View details for PubMedID 37573214

https://orcid.org/0000-0001-8786-9304